Cargando…
Microbiome Responses to Vancomycin Treatment in a Child With Primary Sclerosing Cholangitis and Ulcerative Colitis
The therapeutic effects of off-label oral vancomycin in pediatric and adult primary sclerosing cholangitis (PSC)-inflammatory bowel disease, more commonly PSC-ulcerative colitis (UC), indicate the translational relevance of disease-associated microbiome findings. This is the first report on longitud...
Autores principales: | Britto, Savini Lanka, Hoffman, Kristi Louise, Tessier, Mary Elizabeth, Petrosino, Joseph, Miloh, Tamir, Kellermayer, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116036/ https://www.ncbi.nlm.nih.gov/pubmed/33997090 http://dx.doi.org/10.14309/crj.0000000000000577 |
Ejemplares similares
-
Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis
por: Buness, Cynthia, et al.
Publicado: (2016) -
How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
por: Shah, Ayesha, et al.
Publicado: (2022) -
Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis
por: Cortez, Ramon V., et al.
Publicado: (2021) -
Weight loss is a sufficient and economical single outcome measure of murine dextran sulfate sodium colitis
por: Britto, Savini Lanka, et al.
Publicado: (2019) -
Effect of the Specific Carbohydrate Diet on the Microbiome of a Primary Sclerosing Cholangitis and Ulcerative Colitis Patient
por: Dubrovsky, Alanna, et al.
Publicado: (2018)